CLINICAL_TRIALS trial_result · 2016-01-15

Clinical Trial Update: SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study [Phase 2]

Phase II clinical trial update showing results for SHO-SAIKO-TO in chronic hepatitis C; the study has completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2016-01-15